Comprehensive Clinical Guide: Human Albumin (25% and 5%)
1. Introduction and Clinical Overview
Human Albumin is a sterile, non-pyrogenic preparation of serum albumin obtained from large pools of human venous plasma. As the most abundant protein in human plasma, albumin serves as the primary determinant of plasma oncotic pressure and acts as a critical transport vehicle for endogenous and exogenous substances. In clinical practice, albumin is classified as a plasma volume expander, indicated for the restoration and maintenance of circulating blood volume where a volume deficit has been demonstrated.
Unlike crystalloid solutions (e.g., normal saline or lactated Ringer’s), albumin does not readily extravasate into the interstitial space due to its high molecular weight (~66.5 kDa). This unique pharmacokinetic profile makes it a gold-standard therapeutic agent in managing complex hemodynamic states, particularly in patients with cirrhosis, septic shock, and severe hypoalbuminemia.
2. Mechanism of Action and Pharmacokinetics
Mechanism of Action
The primary therapeutic effect of albumin is the maintenance of colloid oncotic pressure (COP). By increasing the oncotic pressure within the intravascular compartment, albumin facilitates the movement of fluid from the interstitial spaces into the intravascular space, thereby increasing plasma volume.
- Fluid Redistribution: Albumin accounts for approximately 75–80% of the total plasma colloid oncotic pressure.
- Binding and Transport: Albumin possesses multiple binding sites for various ligands, including fatty acids, bilirubin, hormones (thyroxine, cortisol), and pharmacological agents (warfarin, phenytoin).
- Antioxidant Properties: Through its free thiol group (Cys34), albumin acts as a significant scavenger of reactive oxygen species (ROS), providing secondary anti-inflammatory effects in systemic inflammatory response syndromes (SIRS).
Pharmacokinetics
- Distribution: Following intravenous administration, albumin distributes primarily into the intravascular space. In healthy individuals, the total body albumin pool is approximately 350–500 g, with 40% found in the plasma and 60% in the extravascular space.
- Metabolism: Albumin is degraded primarily by lysosomal proteolysis in tissues such as the liver, skin, and muscle.
- Elimination: The half-life of albumin in a healthy adult is approximately 14 to 20 days. In pathological states (e.g., nephrotic syndrome or protein-losing enteropathy), the half-life is significantly shortened.
3. Clinical Indications and Usage
Albumin is indicated for a variety of critical care and surgical conditions. The choice between 5% (iso-oncotic) and 25% (hyper-oncotic) formulations depends on the clinical objective.
| Indication | Recommended Concentration | Rationale |
|---|---|---|
| Hypovolemic Shock | 5% | Rapid volume expansion without fluid overload. |
| Spontaneous Bacterial Peritonitis | 25% | Prevents hepatorenal syndrome by maintaining renal perfusion. |
| Large-Volume Paracentesis | 25% | Prevents paracentesis-induced circulatory dysfunction. |
| Severe Burns (>24h post-injury) | 5% | Restoration of colloid osmotic pressure after capillary leak phase. |
| Nephrotic Syndrome | 25% | Used adjunctively with diuretics to mobilize refractory edema. |
| Liver Transplantation | 5% or 25% | Hemodynamic stabilization during the anhepatic phase. |
Dosage Guidelines
Dosage must be individualized based on the patient’s clinical status, serum albumin levels, and hemodynamic monitoring.
- Hypovolemia: Initial dose of 25g (500mL of 5% or 100mL of 25%) in adults. May be repeated based on response.
- Hypoalbuminemia: Often calculated by the formula: Required dose (g) = (Target Albumin - Current Albumin) × Plasma Volume × 2.
- Spontaneous Bacterial Peritonitis: 1.5 g/kg on day 1, followed by 1 g/kg on day 3.
4. Risks, Side Effects, and Contraindications
Contraindications
- Hypersensitivity: Known history of severe allergic reaction to human albumin or any excipient.
- Severe Anemia: Administration may exacerbate symptoms of anemia due to hemodilution.
- Cardiac Failure: Risk of circulatory overload (pulmonary edema).
- Chronic Nephrosis: Unless used with caution and diuretics.
Potential Side Effects
- Common: Flushing, urticaria, fever, nausea.
- Serious: Anaphylactoid reactions, pulmonary edema (due to fluid overload), and hypotension (if administered too rapidly, particularly with 25% solutions).
- Electrolyte Imbalance: Certain albumin preparations contain sodium (up to 160 mEq/L); monitor patients with sodium-restricted diets or renal impairment.
Pregnancy and Lactation
- Pregnancy Category C: Animal reproduction studies have not been conducted. Albumin is a normal constituent of human plasma; however, it should be used only if clearly indicated, as the effect on the fetus remains under-studied.
- Lactation: Albumin is a normal component of breast milk; no adverse effects on the nursing infant are expected.
5. Drug Interactions and Overdose Management
Drug Interactions
Albumin should not be mixed with other medicinal products, whole blood, or packed red blood cells. It is chemically incompatible with:
* Protein Hydrolysates: May cause precipitation.
* Alcohol-containing solutions: May lead to protein denaturation.
* Vancomycin/Midazolam: Some literature suggests potential binding interactions; avoid co-administration in the same IV line.
Overdose Management
The primary risk of overdose is hypervolemia.
* Symptoms: Headache, dyspnea, jugular vein distension, rales, hypertension, or pulmonary edema.
* Action: Discontinue infusion immediately. Administer diuretics (e.g., Furosemide) to promote diuresis. In severe cases, ultrafiltration or hemodialysis may be necessary to remove excess intravascular volume.
6. Frequently Asked Questions (FAQ)
1. Is Albumin better than crystalloids (Normal Saline)?
In most cases of routine resuscitation, crystalloids are first-line. However, in patients with cirrhosis, septic shock, or those requiring large-volume resuscitation, albumin is superior in maintaining intravascular volume without inducing severe peripheral edema.
2. Can Albumin be used for nutritional support?
No. While albumin is a protein, it is not an efficient source of nitrogen for nutritional support. Amino acid solutions are preferred for parenteral nutrition.
3. Why do I sometimes see 5% and other times 25%?
The 5% solution is iso-oncotic and used primarily for volume replacement. The 25% solution is hyper-oncotic and is used to pull fluid from the extravascular space into the vessels, often used for patients with third-spacing.
4. Does Albumin carry a risk of viral transmission?
Modern pasteurization techniques (heating to 60°C for 10 hours) and rigorous donor screening make the risk of viral transmission (HIV, Hepatitis) extremely low, effectively zero in current clinical practice.
5. How fast should Albumin be administered?
The rate depends on the patient's condition. For 5% albumin, rates up to 5-10 mL/min are common. For 25% albumin, the rate should generally not exceed 1-2 mL/min to prevent circulatory overload.
6. What is "Paracentesis-induced Circulatory Dysfunction" (PICD)?
Removing large amounts of ascitic fluid causes a shift of blood into the peritoneal vasculature, leading to hypotension. Albumin is administered to maintain oncotic pressure and prevent this shift.
7. Does Albumin affect coagulation?
Large-volume administration of albumin may lead to a dilution of clotting factors, potentially resulting in a mild coagulopathy. Monitoring of coagulation profiles (PT/INR/PTT) is advised during massive resuscitation.
8. Is albumin safe for patients with renal failure?
Yes, but with caution. Albumin can be used to treat hypoalbuminemia, but clinicians must monitor for fluid overload and the sodium content of the albumin preparation.
9. Can albumin be stored at room temperature?
Most preparations require storage between 2°C and 25°C. Always check the specific manufacturer’s labeling, as expiration dates vary based on storage conditions.
10. What should I do if the solution is cloudy?
Do not use. If the solution appears turbid or contains particulate matter, it indicates protein denaturation or contamination. Discard the vial immediately.
7. Clinical Summary for Practitioners
When prescribing Human Albumin, the specialist must balance the need for oncotic support against the risk of volume overload. Always verify the concentration (5% vs 25%) prior to initiation, as the clinical implications of an error can be life-threatening. In the orthopedic setting, albumin is frequently utilized in major reconstructive surgeries or complex trauma where significant capillary leak syndrome is anticipated or observed. Always document the indication clearly to ensure adherence to institutional stewardship programs, as albumin is a high-cost blood product.
Disclaimer: This guide is intended for educational purposes for healthcare professionals. Always consult your facility’s specific clinical protocols and the manufacturer’s Package Insert (PI) before administration.